Multi-Center Comparison of Dual Lumen Versus Single Lumen Ureteroscopes
1 other identifier
interventional
156
1 country
1
Brief Summary
Urolithiasis (kidney stones) is a common disease process affecting people all across the world. Usually, if the stone size is small, it is able to pass through the urinary system and exit the bladder on its own with no treatment. However, when the size of the stone is bigger, it can get trapped in the kidney or the ureter, causing significant pain for the patient and potentially obstructing urine flow. If this occurs, surgical treatment is necessary for the removal of the stone. The surgical procedure often employed involves the use of a ureteroscope, which is a device that includes a camera and channels for working instruments such as a grasper and laser fiber to be placed during a procedure. Ureteroscopes that are currently in use are flexible and have the ability to treat stones that may otherwise be inaccessible in the kidney. Most flexible ureteroscopes in clinical use currently only have one channel therefore only allowing one instrument to be used at a time. Recently, a new type of ureteroscope has been introduced in the market that offers the advantage of having two working channels where two instruments can be inserted for use during stone treating procedure. This can potentially decrease procedure time for patients affected by kidney stones. The purpose of this research is to compare the efficacy and safety of the ureteroscopes that have only one channel for instrument insertion with the newer ureteroscope that has two channels for utilization during stone treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2014
CompletedFirst Posted
Study publicly available on registry
April 25, 2014
CompletedStudy Start
First participant enrolled
July 2, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2021
CompletedMarch 13, 2025
March 1, 2025
6.8 years
March 26, 2014
March 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time
The primary outcome of the proposed study will be the procedure time in minutes measured from the start of the endoscopic access to the end of the procedure including complete fragmentation and stone fragment removal.
Day 1 (Day of procedure)
Secondary Outcomes (3)
Complications
Days 1-30
Time
Days 1-30
Device efficacy
Procedure day
Study Arms (2)
Single-Lumen Ureteroscope
OTHERSubjects enrolled in this study arm will have their procedure performed using the single lumen ureteroscopes. This scope is currently employed in clinical practice, including at UC Irvine Medical Center.
Dual Lumen Ureteroscope
EXPERIMENTALSubjects enrolled in this study arm will have their procedure performed using the dual lumen ureteroscopes. This scope is currently employed in clinical practice, including at UC Irvine Medical Center.
Interventions
Single lumen, flexible scope for ureteroscopies
Dual lumen, flexible scope for ureteroscopies
Eligibility Criteria
You may qualify if:
- Patients \>18 years old.
- Patients with \<2 cm total burden of renal or ureteral stones eligible for flexible ureteroscopic lithotripsy.
You may not qualify if:
- Patients \<18 years old.
- Patients who are not able to give consent for study
- Patients with active urinary tract infection
- Pregnant women
- Patients who have had ureteroscopy, SWL or PCNL for the same stone on the ipsilateral kidney
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Irvine Medical Center
Orange, California, 92868, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jaime Landman, MD
University of California, Irvine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Urology and Radiology
Study Record Dates
First Submitted
March 26, 2014
First Posted
April 25, 2014
Study Start
July 2, 2014
Primary Completion
April 1, 2021
Study Completion
April 1, 2021
Last Updated
March 13, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share